Search

everythinglearnresearchcommunity

for

Search:↓

MRI helps evaluate androgenetic alopecia severity.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

NSAIDs may not affect soft tissue healing but should be used carefully for bone fractures and more research is needed to understand sex differences in response.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Ziziphus jujuba Mills may have health benefits, but more research is needed to confirm its safety and effectiveness.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Capsaicin, found in chili peppers, can slow down hair growth by affecting skin cells and hair follicles.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

A protein called desmoglein 3 is important for keeping hair follicle stem cells inactive and helps in their regeneration.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

The document concludes that molluscum contagiosum is a common, benign skin infection in children, often healing without scarring.

Follicle Stimulating Hormone is important for fertility.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

The document discusses how to diagnose and treat conditions like acne, excessive hair growth, and female pattern hair loss related to hormone imbalances.

sPLA2-X is crucial for normal hair growth and follicle health.

Foxn1 gene regulation is crucial for thymus development but not for hair growth.

Surface-modified nanoparticles mainly use non-follicular pathways to enhance skin permeation of ibuprofen and could improve treatment for inflammatory skin diseases.

Phospholipase A2 enzymes play key roles in skin health and disease.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Certain cells from hair follicles can create new hair and contribute to hair growth when implanted in mice.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

The symposium concluded that environmental factors significantly contribute to skin aging.

Taking vitamin C and vitamin E twice a day can help prevent sunburn and DNA damage from UVB exposure.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

The document concludes that hair follicles have a complex environment and our understanding of it is growing, but there are limitations when applying animal study findings to humans.